|
 |
| |
|
·»¹Ù´Õĸ½¶10mg(·»¹ÙƼ´Õ¸Þ½Ç»ê¿°µð¸ÞÆ¿¼³Æø½Ãµå) Lenvanib Cap. 10mg
|
|
Àü¹®ÀǾàǰ | ±Þ¿©
|
|
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| Èò»ö ³»Áö ¹Ì»öÀÇ °ú¸³ÀÌ ÃæÁøµÈ »óºÎ ÁÖȲ»ö, ÇϺΠ³ë¶õ»öÀÇ Ä¸½¶
|
|
|
|
|
|
Á¦Á¶È¸»ç |
(ÁÖ)º¸·É
|
ÆÇ¸Åȸ»ç |
(ÁÖ)º¸·É
|
Çã°¡Á¤º¸ |
Á¤»ó
(2025.02.06)
|
BIT ¾àÈ¿ºÐ·ù |
Ç¥ÀûÄ¡·á Ç×¾ÏÁ¦(Targeted cancer therapy)
|
º¹ÁöºÎºÐ·ù |
421[Ç׾ǼºÁ¾¾çÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
641908580 \26,765 ¿ø/1ĸ½¶(2025.07.01)(ÇöÀç¾à°¡)
|
|
|
ATCÄÚµå |
lenvatinib / L01EX08 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
ÀúġȯµµÈ÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
Á¤Á¦¼ö,
ź»ê¼ö¼Ò³ªÆ®·ý,
ÅÅÅ©,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
È÷ÇÁ·Î¸á·Î¿À½ºÄ¸½¶,
D-¸¸´ÏÅç
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-12-21 |
|
|
|
|
| |
|
|
|